Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7163824 | 0.96 | CYP3A4 (0.43) | CYP3A4TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL218680 | 0.87 | CYP3A4 (0.56) | CYP3A4TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL3628432 | 0.83 | CYP3A4 (0.46) | CYP3A4TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL10883803 | 0.81 | CYP3A4 (0.45) | CYP3A4TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL3757863 | 0.79 | MAPT (0.40) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL1913724 | 0.78 | CYP3A4 (0.41) | CYP3A4TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL3759313 | 0.78 | ALDH1A1 (0.41) | CYP3A4TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL10945329 | 0.75 | SRC (0.47) | CYP3A4TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL4990431 | 0.75 | MAPT (0.40) | CYP3A4TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL27743221 | 0.75 | HPGD (0.40) | CYP3A4TSHRALDH1A1MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298506-A1 | METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2010-11-25 | — | — | US | disclosed |
| CN-101617014-A | Flame-retardant adhesive composition, flexible copper-clad laminate and coverlay film | SHOWA HIGHPOLYMER | 2009-12-30 | — | — | CN | disclosed |
| CN-101460511-A | Method for producing amino group-containing phosphate ester compound, flame-retardant resin, and flame-retardant resin composition | SHOWA HIGHPOLYMER (JP) | 2009-06-17 | — | — | CN | disclosed |
| EP-2036911-A1 | PROCESS FOR PRODUCTION OF AMINATED PHOSPHORIC ACID ESTER COMPOUND, FLAME-RETARDANT RESIN, AND FLAME-RETARDANT RESIN COMPOSITION | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2009-03-18 | — | — | EP | disclosed |
| US-4556684-A | ADDING A ALKYL SUBSTITUTED TRIPHENYL PHOSPHATES | FMC CORPORATION (US) | 1985-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298506-A1 | METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION | ATIC, GART, RPP30 | CYP3A4 2190/4885TSHR 2372/4885ALDH1A1 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.